Companies / Aprea Therapeutics, Inc.
Aprea Therapeutics, Inc.
Nasdaq: APRECIK 1781983DOYLESTOWN, PA
Financials
Ownership
12.6M shares outstanding · as of Aug 12, 2026
Ownership
| Insiders | 3.58% | 450,787 |
| Institutions | 19.51% | 2,456,437 |
| Public float | 76.91% | 9,683,912 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 3
View all →| Insider | % of shares | Shares |
|---|---|---|
Gilad OrenCEOPresident/CEO · Director | 3.13% | 393,895 |
Hamill John P.SrVP/CFO/Prin Fin & Acct Ofcr | 0.35% | 43,528 |
Henneman John B IIIDirector | 0.11% | 13,364 |
Institutional holders 24
View all →| Holder | Value | % of shares |
|---|---|---|
| $814.8K | 8.07% | |
| $290.1K | 2.70% | |
| $230.3K | 2.14% | |
| $175.5K | 1.63% | |
| $102.9K | 0.96% | |
| $90.9K | 0.95% | |
| $65.7K | 0.61% | |
| $49.5K | 0.46% | |
| $43.5K | 0.41% | |
| $39.8K | 0.37% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jan 30, 2026 | Gilad Oren CEO | Buy | Common Stock | $25.0K | +28K +8.13% | 373,720 2.97% of shares | low |
| Jan 30, 2026 | Hamill John P. Executive | Buy | Common Stock | $5.1K | +6K +20.55% | 33,433 0.27% of shares | low |
| Jun 16, 2026 | Henneman John B III Director | Grant | Common Stock | $0 | +3K +30.65% | 13,364 0.11% of shares | low |
| Mar 12, 2026 | Gilad Oren CEO | Grant | Common Stock | $0 | +20K +5.40% | 393,895 3.13% of shares | low |
| Mar 12, 2026 | Hamill John P. Executive | Grant | Common Stock | $0 | +10K +30.19% | 43,528 0.35% of shares | low |
| Jun 16, 2026 | Henneman John B III Director | Grant | Stock Options (Right to Buy) | — | +13K | 12,555 0.10% of shares | low |
| Mar 12, 2026 | Gilad Oren CEO | Grant | Stock Options (Right to Buy) | — | +81K | 80,700 0.64% of shares | low |
| Mar 12, 2026 | Hamill John P. Executive | Grant | Stock Options (Right to Buy) | — | +40K | 40,380 0.32% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Orin Hirschman | Passive13G/A | — |
| Nantahala Capital Management, LLC | Passive13G/A | — |
| Orin Hirschman | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| APRE | Common Stock | 03836J201 |
| APRE | — | 03836J102 |